Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
0.2845
-0.0215 (-7.03%)
At close: Jun 27, 2025, 4:00 PM
0.2900
+0.0055 (1.93%)
After-hours: Jun 27, 2025, 7:59 PM EDT
Aspire Biopharma Holdings Market Cap
Aspire Biopharma Holdings has a market cap or net worth of $13.91 million as of June 27, 2025. Its market cap has decreased by -86.89% in one year.
Market Cap
13.91M
Enterprise Value
19.33M
1-Year Change
-86.89%
Ranking
Category
Stock Price
$0.28
Market Cap Chart
Since April 11, 2022, Aspire Biopharma Holdings's market cap has decreased from $349.65M to $13.91M, a decrease of -96.02%. That is a compound annual growth rate of -63.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 13.91M | -84.42% |
| Dec 18, 2024 | 89.30M | -8.80% |
| Dec 29, 2023 | 97.91M | -73.55% |
| Dec 30, 2022 | 370.16M | 5.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |